Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
416 participants
OBSERVATIONAL
2015-05-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hospital Discharge Oral Nutrition Support Trial
NCT02051777
The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity
NCT00946816
Hunger and Satiety in Anorexia Nervosa
NCT02932046
Effectiveness of Stepped Care Versus Best Available Care for Bulimia Nervosa
NCT00733525
Funen Anorexia Nervosa Study - Retrospective Cohort Study and 10 Year Follow-up Study
NCT00267228
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Center : Geneva University Hospital (HUG), site of Cluse-Roseraie.
Design : Quality control prospective observational survey.
Population : Hospitalized adults patients with Oral Nutritive Supplements (ONS). Four hundred patients to be included.
Duration : Inclusion from April to December 2015 (9 months).
Hypothesis : At hospital discharge for home, the medical prescription of ONS according to the official criteria of SSNC and the legal regulations (completed prescription according to health's insurance and homecare delivery) dictates the compliance of the patient and the reimbursement of the ONS.
Aims : The primary aim is to document the existence of an ONS medical prescription during the hospitalization and at hospital discharge for home.
The secondary aims are to describe :
* NRS 2002 score when prescribing ONS during the hospitalization, at hospital discharge for home and one month after hospital discharge for home
* Indications for ONS prescription at hospital discharge for home according to the official criteria of SSNC
* Type of ONS prescription at hospital discharge for home
* Number of ONS consumed one month after hospital discharge compared to prescription at hospital discharge
* Timing of the discontinuation of the ONS treatment
* Reasons for stopping the ONS intake.
Methods : Included are all hospitalized adults patients with ONS prescription at the HUG. Excluded are patients with ONS delivery by a homecare before the admission at the HUG or patients refusing to consume ONS or patients with major disorders of consciousness (ex : dementia) or patients unable to consume ONS (ex : dysphagia, dysfunction of upper limbs, etc.) or patients refusing to participate to the survey.
At inclusion, the comorbidities will be assessed by the Charlson Comorbidity Index. ONS prescription and nutritional risk by the NRS 2002 score will be described at hospital and at hospital discharge for home. One month after hospital discharge for home, patient's compliance to ONS will be assessed as nutritional risk by the NRS 2002 score.
Statistics : Data will be presented as mean ± standard deviation or as numbers and percentages according to the relevance, and analyzed using Chi-squared test or unpaired t-test as required.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral nutritive supplements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalization in medical and surgical wards of the Geneva University Hospital, site of Cluse-Roseraie
* Oral nutritive supplements prescription during hospitalization
Exclusion Criteria
* Patient refusal to consume oral nutritive supplements
* Major disorders of consciousness (ex : dementia)
* Physical impossibility to consume Oral nutritive supplements (ex : dysphagia, dysfunction of upper limbs, etc.)
* Patient refusal to participate to the survey
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Claude Pichard
Professor of Nutrition and Head of Clinical Nutrition Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claude Pichard, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geneva University Hospital
Geneva, Canton of Geneva, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mareschal J, Altwegg J, Berthet D, Chikhi M, Chopard P, Graf S, Sierro C, Pichard C, Genton L. Prescription and indication for oral nutritional supplements in a Swiss university hospital: a prospective survey. Swiss Med Wkly. 2017 Aug 3;147:w14475. doi: 10.4414/smw.2017.14475. eCollection 2017.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Quality program ONSHUG 2015-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.